Peter Inglesby
Impact in
-
- Antibiotic Use and Resistance
-
- COVID-19 epidemiological studies
Papers in
- Oncology 3
- COVID-19 and healthcare impacts 3
-
- Antibiotic Use and Resistance 3
- Co-authors
- Georgia C. Richards (1 shared paper)Nicholas DeVito (2 shared papers)Seb Bacon (13 shared papers)Brian MacKenna (13 shared papers)Ben Goldacre (13 shared papers)Louis Fisher (7 shared papers)Simon Davy (5 shared papers)Amir Mehrkar (7 shared papers)
- Journals
- British Journal of General Practice (2 papers)Journal of Infection (1 paper)BMC Medicine (1 paper)British Journal of Clinical Pharmacology (1 paper)EClinicalMedicine (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Peter Inglesby
12 papers receiving 96 citations
Peers
Comparison fields: 5 of 42
- Applied Microbiology and Biotechnology 19
- Modeling and Simulation 3
- Oncology 16
- General Health Professions 13
- Infectious Diseases 6
Countries citing papers authored by Peter Inglesby
This map shows the geographic impact of Peter Inglesby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Inglesby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Inglesby more than expected).
Fields of papers citing papers by Peter Inglesby
This network shows the impact of papers produced by Peter Inglesby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Inglesby. The network helps show where Peter Inglesby may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Inglesby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 33 | |
| 2 | 2020 | 17 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 9 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2022 | 0 | |
| 15 | 2025 | 0 |
About Peter Inglesby
Peter Inglesby is a scholar working on Oncology, Applied Microbiology and Biotechnology, General Health Professions, Information Systems and Management and Artificial Intelligence, having authored 15 papers that have together received 96 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (3 papers), COVID-19 and healthcare impacts (3 papers), Scientific Computing and Data Management (1 paper), Global Health Care Issues (1 paper), Healthcare Policy and Management (1 paper), Healthcare Systems and Challenges (1 paper), Topic Modeling (1 paper) and Data Quality and Management (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Modeling and Simulation (3 citations), Oncology (16 citations), General Health Professions (13 citations) and Infectious Diseases (6 citations). Peter Inglesby has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Georgia C. Richards, Nicholas DeVito, Seb Bacon, Brian MacKenna, Ben Goldacre, Louis Fisher, Simon Davy, Amir Mehrkar, John Macleod and Alex J Walker. Their work appears in journals such as British Journal of General Practice, Journal of Infection, BMC Medicine, British Journal of Clinical Pharmacology and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.